UnitedHealth (UNH) vs Walmart (WMT)

UNH closed at $366.77 on April 29, 2026, with a market cap of $336.47 billion. Q1 2026 results: EPS $7.23 versus $6.58 consensus (a 9.9 percent beat), revenue beat. UNH raised full-year 2026 EPS guidance to more than $18.25 per share (up from $17.75 prior). Quarterly dividend $2.21 per share ($8.84 annualized, yield 2.41 percent).

WMT closed at $126.58 on April 29, 2026, with a market cap of approximately $1,020 billion. Most recent quarter revenue grew 5.1 percent year-over-year with continued margin pressure from e-commerce build-out. Quarterly dividend $0.248 ($0.99 annualized, yield 0.78 percent). WMT trades at approximately 35x forward earnings versus UNH at approximately 20x forward earnings, reflecting different growth profiles despite both being defensive.

UNH and WMT are both classified as defensive names with low beta to SPY (UNH approximately 0.75, WMT approximately 0.65), but they protect against different things. UNH protects against macro slowdown because medical care utilization is highly inelastic: people see doctors and take medications independently of the business cycle. WMT protects against consumer spending pressure because grocery and household staples are the last category to see spending cuts during recession.

The difference matters during stress episodes. The 2020 COVID shock initially hurt UNH (deferred elective procedures collapsed care utilization, hurting MLR margins favorable in the short-term but signaling unsustainable cost spikes later) while helping WMT (panic buying drove +20 percent comp store sales). The 2008 to 2009 GFC was the cleanest defensive divergence: UNH was approximately flat while WMT rose +18 percent. The pattern: WMT is more reliably defensive across all recession types; UNH is more defensive in slow-growth environments but vulnerable to acute care-utilization shocks.

UnitedHealthcare's 2026 Medicare Advantage plans will be available to 94 percent of Medicare eligibles, maintaining its position as the nation's largest MA carrier. The company prioritized $0 premiums on most plans, $0 copays for primary care, and Tier 1 prescription coverage with dental, vision, and hearing benefits.

Medicare Advantage is UNH's growth engine: enrollment has compounded approximately 7 percent annually for a decade. The 2026 enrollment cycle saw UNH add net new members despite exiting some unprofitable plans. The CMS Medicare Advantage rate update for 2026 was favorable (net rate increase) after 2024 and 2025 saw squeezes that hurt MLR. The Q1 2026 EPS beat reflects MLR returning to the lower end of UNH's 84 to 86 percent target range. The forward setup: continued MA enrollment growth plus MLR stabilization at favorable levels could drive 2026 EPS above the raised $18.25 guidance, but the forward catalyst is the November 2026 election and any resulting CMS policy shifts.

UnitedHealth went through one of its most challenging years in decades in 2025. Higher than expected medical-cost trend (driven by post-COVID care normalization, GLP-1 obesity drug utilization, and inpatient cost inflation) caused medical-loss ratio to rise to approximately 86 to 87 percent versus the historical 83 to 85 percent target. The company also exited certain Medicare Advantage PPO plans serving approximately 600,000 members effective 2026 because they were unprofitable at current reimbursement rates.

The 2025 stress was reflected in stock performance: UNH fell from peak $620 in late 2024 to approximately $440 trough in mid-2025 (-29 percent peak-to-trough). The current $366.77 reflects continued recovery from that trough but not back to 2024 highs. The Q1 2026 beat suggests the worst is behind UNH; the raised guidance signals management confidence. But the lesson from 2025 is that UNH is not bulletproof defensive: care-utilization shocks can hit margins meaningfully.

WMT's recent quarters have shown a steady but unspectacular pattern: revenue growth around 5 percent, comp-store sales 2 to 3 percent, with margin pressure from e-commerce mix shift. The most distinctive WMT signal is its disclosure of higher-income customer share, which rose substantially in 2024 to 2025 as consumers facing persistent inflation pressure traded down to discount channels.

WMT US e-commerce now represents 13 percent of total US sales (up from 6 percent five years ago) and has been growing approximately 22 percent annually. The growth is impressive but margin-dilutive: e-commerce operating margins are 200 to 400 basis points lower than store margins because of fulfillment, last-mile delivery, and ad-tech investment costs. Operating margin has compressed from 4.3 percent (2019) to approximately 4.0 percent currently, with management guiding to flat-to-slight-margin expansion in 2026 from automation investments. The story is "growth at the cost of operating leverage" rather than "scaling efficiency."

During the 2008 to 2010 GFC and aftermath, UNH and WMT diverged meaningfully. WMT rose from $44 (December 2007) to peak $58 (May 2010), a +32 percent gain over 30 months while SPY fell -50 percent peak-to-trough. UNH was approximately flat over the same window: $52 (December 2007) to $35 trough (March 2009) to $34 (May 2010), a -35 percent peak-to-trough drawdown that fully recovered to flat by May 2010.

The pattern: WMT was the more reliably defensive name during the financial crisis because its grocery and staples revenue was actually accretive (consumers traded down). UNH suffered initially from health-care reform uncertainty (the Affordable Care Act was being debated and passed during this period) plus general healthcare spending pressure. The 2008 to 2010 episode established the canonical template: WMT is the cleaner defensive in financial crises; UNH is the cleaner defensive in slow-growth-no-crisis environments.

The 2022 to 2024 inflation cycle saw UNH dramatically outperform WMT. UNH rose from approximately $400 (early 2022) to peak $620 (late 2024), a +55 percent gain. WMT rose from approximately $145 to approximately $190 over the same window, a +31 percent gain (after adjusting for the 2024 3-for-1 stock split that took the price from $585 to $195 per share).

Then 2025 inverted the pattern. UNH fell from $620 to $440 (-29 percent peak-to-trough) on MLR pressure and the Medicare Advantage rate squeeze. WMT continued steady growth, returning approximately +12 percent in 2025 alone. The pair captured the regime change: UNH was a momentum/growth winner during the inflation period because care-utilization was running hot; WMT was the steady defensive that benefited when UNH stumbled. The 2024 to 2025 episode was a textbook lesson that "defensive" classification is not constant across all stress types.

UNH outperforms WMT in slow-growth environments where the economy decelerates but does not enter financial crisis. The 2014 to 2016 period: UNH +75 percent, WMT -10 percent. The 2018 to 2019 late-cycle: UNH +45 percent, WMT +20 percent. The 2022 to 2024 disinflation period: UNH +55 percent, WMT +31 percent.

The pattern: UNH thrives in stable-growth-with-modest-inflation environments because Medicare Advantage enrollment grows steadily, MLR remains favorable, and pricing power can offset cost trend. The April 2026 setup currently looks like a UNH-favorable environment: care utilization stable, MA rates favorable for 2026, growth path intact. The risk to UNH is renewed care-cost inflation (GLP-1 obesity drugs continuing to ramp) or election-driven Medicare Advantage rate squeezes after the November 2026 cycle.

For diversified equity allocations, UNH and WMT often appear together as defensive complements. A practical framework: in a 60 percent equity / 40 percent bond portfolio, allocate 2 to 4 percent to UNH and 2 to 4 percent to WMT as part of the equity allocation. The combination provides broader defensive coverage than either alone because they protect against different stress types.

The allocation case shifts with regime. In environments where inflation is rising and the Fed is hiking (2022 to 2024), tilt the defensive bucket toward UNH. In environments where recession risk is elevated and financial stress is plausible (current April 2026 mid-cycle slowdown), tilt toward WMT. Equal weight 2 to 3 percent each is the regime-neutral default. Both are mega-cap names with strong dividends (UNH 2.41 percent, WMT 0.78 percent) and demonstrable through-cycle resilience, even if 2025 reminded investors that resilience does not mean immunity.